At a glance
ClinicalIndex Comparison RecordN/ACompleted· 75 enrolled
Drug / intervention
Experimental: methylphenidate treatmentdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Brain Dopamine Function in Adults With ADHD
In Brief
A clinical study evaluating Experimental: methylphenidate treatment for Attention Deficit Hyperactivity Disorder. Completed, enrolled 75 participants across 1 site.
Detailed Summary
The purpose of the study is to investigate the functional state of dopamine cells and the dopamine transporter in ADHD subjects and controls to assess the effects of chronic methylphenidate treatment on dopamine cell function and dopamine transporter levels in ADHD subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAttention Deficit Hyperactivity Disorder
CountriesUnited States
CollaboratorsIcahn School of Medicine at Mount Sinai, Duke University
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2006
First PostedDec 2007
Primary CompletionMar 2009
Study CompletionApr 2009
TodayJul 2026
First PostedDec 27, 2007
Enrollment StartFeb 1, 2006
Primary CompletionMar 1, 2009
Study CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 18.5 years ago
Interventions
Experimental: methylphenidate treatmentdrug
subjects received mehtylphenidate treatment for 12 months